As European markets experience a positive uptick with the pan-European STOXX Europe 600 Index rising 2.77% amid easing trade tensions, investors are keenly observing opportunities to strengthen their portfolios. In such an environment, dividend stocks can offer a reliable income stream and potential for growth, making them attractive options for those looking to enhance their investment strategies in the current market landscape.
Name | Dividend Yield | Dividend Rating |
Julius Bär Gruppe (SWX:BAER) | 4.88% | ★★★★★★ |
Zurich Insurance Group (SWX:ZURN) | 4.39% | ★★★★★★ |
Bredband2 i Skandinavien (OM:BRE2) | 4.61% | ★★★★★★ |
OVB Holding (XTRA:O4B) | 4.42% | ★★★★★★ |
S.N. Nuclearelectrica (BVB:SNN) | 9.22% | ★★★★★★ |
HEXPOL (OM:HPOL B) | 5.02% | ★★★★★★ |
Deutsche Post (XTRA:DHL) | 4.93% | ★★★★★★ |
Cembra Money Bank (SWX:CMBN) | 4.27% | ★★★★★★ |
Rubis (ENXTPA:RUI) | 7.11% | ★★★★★★ |
Banque Cantonale Vaudoise (SWX:BCVN) | 4.34% | ★★★★★★ |
Click here to see the full list of 234 stocks from our Top European Dividend Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Construcciones y Auxiliar de Ferrocarriles, S.A. is a company specializing in the design, manufacture, and maintenance of railway vehicles and equipment, with a market cap of approximately €1.47 billion.
Operations: Construcciones y Auxiliar de Ferrocarriles, S.A. generates revenue primarily from its Railway segment, including wheel sets and components, amounting to €3.29 billion and from its Buses segment contributing €926.87 million.
Dividend Yield: 3.1%
Construcciones y Auxiliar de Ferrocarriles (CAF) offers a mixed picture for dividend investors. While the company trades at 43.3% below its estimated fair value, providing potential capital appreciation, its dividend yield of 3.12% is lower than the Spanish market's top tier. Despite a well-covered payout ratio of 44.4%, CAF's dividends have been volatile over the past decade, lacking reliability and stability even as earnings and sales show growth with EUR 4.22 billion in sales for 2024.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Clínica Baviera, S.A. is a medical company that operates a network of ophthalmology clinics across Spain and Europe, with a market cap of €575.76 million.
Operations: Clínica Baviera, S.A. generates its revenue primarily from its ophthalmology clinics, with a total of €265.72 million.
Dividend Yield: 4.4%
Clínica Baviera's dividend profile shows both strengths and weaknesses for investors. While dividends are covered by earnings (66.6% payout ratio) and cash flows (69.3% cash payout ratio), their history is marked by volatility, with unstable payments over the past decade. Despite trading 26.3% below fair value, its 4.36% yield falls short of Spain's top-tier payers. Recent financial results highlight growth, with sales rising to €265.72 million and net income reaching €40.21 million in 2024.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Betsson AB (publ) operates and manages an online gaming business across various regions including the Nordic countries, Latin America, Western Europe, Central and Eastern Europe, Central Asia, and internationally with a market cap of SEK23.40 billion.
Operations: Betsson AB's revenue primarily comes from its operations in online gaming across diverse international markets.
Dividend Yield: 4.2%
Betsson's dividend profile offers a mixed view. While the company has proposed an ordinary dividend of €0.657 per share and a special dividend of €0.10, its history shows volatility with unreliable payments over the past decade. However, dividends are well covered by earnings (49.8% payout ratio) and cash flows (34.8% cash payout ratio). Recent Q1 2025 results showed growth, with sales at €293.7 million and net income at €48.2 million, supporting potential future payouts amidst ongoing M&A strategies.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:CAF BME:CBAV and OM:BETS B.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。